An Updated Evaluation of Multiple Sclerosis Outcomes After Immune Checkpoint Inhibitors from the FAERS Database (P12-6.008)
To describe the outcomes of multiple sclerosis (MS) reported as an adverse event after immune checkpoint inhibitor (ICI) treatment using the FDA Adverse Event Reporting System (FAERS).
Authors
- John L. Villano (ORCID: https://orcid.org/0000-0001-5583-0093)
- Catherine R. García (ORCID: https://orcid.org/0000-0002-6361-0127)
- Niharika Reddy (ORCID: https://orcid.org/0009-0002-9987-0999)
- Julia Magsam
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Kentucky (US)
- Georgetown College (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212587
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00